GRP Mexico Receives ISO 9001:2015 Certification
On February 2, 2023, Global Regulatory Partner Mexico (GRP-Mexico) received their ISO 9001:2015 Certification. The ISO Process started almost a year ago and the QA
GRP Japan Introduces its MAH Capabilities to PMDA Regulators
Overview: On January 16, 2023, GRP Japan executives meet with a team of PMDA regulatory to introduce their MAH Capabilities in Japan. GRP-Japan has been
GRP USA Receives first IND approval of the Year by FDA.
On January 11th, 2023, GRP received the years’ first IND approval from FDA. The sponsor’s product, WS015, is indicated for Hyperuricemia (HUA). HUA is a metabolic
GRP Korea Office is moving near Samseong Station
On January 2023, GRP Korea will be moving its office from Seoul Square to a new office near Samseong Station in Seoul. Office will be
GRP Japan becomes Quasi-Drug MAH licensed by PMDA
GRP Japan broadened this product registration portfolio on November 1st 2022, when the PMDA approved them for MAH license of Quasi-Drugs in Japan. The license
GRP Mexico Receives Sanitary License from Cofepris for Biological products
about grp’s new sanitary license On October 7, 2022, GRP-Mexico received approval from Cofepris for Sanitary License for Biological Products. GRP License allows for the